Morinda citrifolia Leaf Induced Leukemia Cells Apoptosis and Produced Synergistic Effects with Zerumbone
DOI:
https://doi.org/10.37591/rrjols.v6i3.2400Abstract
Leukemia is the most common cancer among children and the 7th most common cancer worldwide. The vegetable Morinda citrifolia leaves was investigated and compared with Zerumbone (a known anti-leukemia compound) separately and in combination, for their apoptotic effects on murine myelomonocytic leukaemia cell line (WEHI-3B). Zerumbone, a sesquiterpene from Zingiber zerumbet was anti-cancer via suppressing free radical generation, inflammation, cancer cell proliferation, metastasis, anti-apoptosis, NF-κβ, Iκβα kinase activation and invasion. The Morinda leaf extract (standardized to the coumarin scopoletin and the flavonoid epicatechin) dose-dependently inhibited WEHI-3B cells proliferation with an IC50 of 17.1±0.1 μg/ml after 72 h incubations. Comparatively, the leaf extract alone and in combination with Zerumbone significantly suppressed WEHI-3B cells with an IC50 of 11.0 and 9.4 μg/ml, respectively. The extract arrested leukemia cells at the G0/G1 phase, and induced apoptosis via the activation of caspase-3 and caspase-8 (death receptor extrinsic pathway). Zerumbone arrested WEHI-3B cell cycle at the G2/M phase and induced apoptosis via the activation of caspase-3 and caspase-9 (intrinsic pathway). When combined, the Zerumbone and Morinda leaf extract indicated synergistic anti-leukemia effects via both the intrinsic and extrinsic pathways, and showed no toxicity to normal cells. Dietary vegetable complementary therapy helps support the primary cancer treatments.
Keywords: Morinda citrifolia, Zerumbone, synergy, leukemia, apoptosis
Cite this Article
Ahmadi N, Rahman HS, Rosli R et al. Morinda citrifolia leaf induced leukemia cells apoptosis and produced synergistic effects with Zerumbone. Research & Reviews: A Journal of Life Sciences. 2016; 6(3): 24–32p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |
